Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (Q928723)

From MaRDI portal
Revision as of 11:46, 28 June 2024 by ReferenceBot (talk | contribs) (‎Changed an Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks
scientific article

    Statements